Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
Xiaopeng Tian, Jun Cai, Yi Xia, et al.
The Lancet Haematology (2024) Vol. 11, Iss. 5, pp. e336-e344
Closed Access | Times Cited: 10

Showing 10 citing articles:

Prognostic value of interim [18F]FDG PET/CT after immunotherapy-based combinations in extranodal NK/T-cell lymphoma, nasal type
Lei Liu, Shihui Hao, Wanqi Chen, et al.
European Radiology (2025)
Closed Access
Efficacy of anti‐PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA
Amira Marouf, Sammara Chaubard, Raphaël Liévin, et al.
HemaSphere (2025) Vol. 9, Iss. 1
Open Access
Orbital natural killer/T-cell lymphoma: a comprehensive case series and literature review
Jing Li, Tingting Ren, Rui Liu, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Peripheral T‐ and natural killer‐cell lymphomas: ESMO‐EHA Clinical Practice Guideline for diagnosis, treatment, and follow‐up
Francesco d’Amore, Massimo Federico, Laurence de Leval, et al.
HemaSphere (2025) Vol. 9, Iss. 5
Open Access
Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up
Francesco d’Amore, Massimo Federico, Laurence de Leval, et al.
Annals of Oncology (2025)
Closed Access
Functional screening of somatic mutant events in extranodal natural killer/T-cell lymphoma with adrenal involvement
Luxin Zhang, Haifeng Gao, Shuang Ma, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Gemcitabine–oxaliplatin as a bridge therapy toward autologous hematopoietic stem cell transplantation in infant-type brain tumors
B Castelli, Carla Fonte, Marco Tellini, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
A prospective phase 2 study of combination epigenetic therapy against relapsed/refractory peripheral T cell lymphoma
Kaiyang Ding, Hailing Liu, Haiyan Yang, et al.
Med (2024) Vol. 5, Iss. 11, pp. 1393-1401.e2
Closed Access | Times Cited: 3
First-line immunochemotherapy for extranodal natural killer/T cell lymphoma
Shu‐Nan Qi, Ye‐Xiong Li
The Lancet Haematology (2024) Vol. 11, Iss. 5, pp. e311-e313
Closed Access | Times Cited: 1
Optimizing the combination of chemotherapeutic drugs along with radiotherapy for extranodal NK/T-cell lymphoma
Fei Luo, Qiuzi Zhong, Xin Liu, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Sustained Remission of Relapsed Extranodal NK/T‐Cell Lymphoma After Treatment With Camrelizumab Plus P‐GEMOX and Autologous Stem Cell Transplantation: A Case Report
Kun Yang, Jian Xiao, Wenqiang Kong, et al.
Pediatric Blood & Cancer (2024) Vol. 72, Iss. 1
Closed Access
Advances in peripheral T cell lymphomas: pathogenesis, genetic landscapes and emerging therapeutic targets
Alexander Pichler, Catalina Amador, Ayumi Fujimoto, et al.
Histopathology (2024) Vol. 86, Iss. 1, pp. 119-133
Open Access
Page 1

Scroll to top